Point72 Asset Management’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History
Bought
Maintained
Sold
Other funds holding FUSN
PA
APM
DM
PCM
JJ
TGA
Point72 Asset Management's FUSN Position: Q1 2024 in Review
Point72 Asset Management sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q1 2024, closing a stake of 293,611 shares — an estimated $2.82M sold.
Point72 Asset Management first reported a position in FUSN in Q2 2020 and held it in 14 quarters. The position peaked at $8.04M in Q1 2021. 114 funds tracked by Wall St. Rank hold FUSN as of Q1 2024.
- Point72 Asset Management reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q1 2024 after selling out during the quarter.
- Point72 Asset Management sold 293,611 Fusion Pharmaceuticals Inc. Common Shares shares in Q1 2024, an estimated $2.82M.
- Point72 Asset Management first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q2 2020 and held it in 14 quarters.
- Point72 Asset Management's Fusion Pharmaceuticals Inc. Common Shares position peaked at $8.04M in Q1 2021.
- 114 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q1 2024.
Based on Point72 Asset Management's 13F filing for Q1 2024, filed 15 May 2024.